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1. Introduction
Tissue culture has become the backbone of research in the life sciences. Large numbers of
primary cells and established cell lines are available from the American Type Culture Collec‐
tion (ATCC, Manassas, VA) and various other sources. Some cell types are relatively easy to
grow and maintain in culture while other cell lines have specific handling issues that must be
learned. These cells come from a variety of animal and human sources and are being used for
research as well as the production of enzymes, hormones, and other biological compounds.
Toxicology applications range from the use of cells as indicator systems for environmental
pollutants to screening cosmetic formulations, new drugs and household chemicals for
potential risks. Such biodetector systems may involve cells from almost any vertebrate or
invertebrate species. In addition, the universal demand for a reduction of the use of animals
in research has prompted the development of alternative methods to determine applicability
of new products or procedures. New technologies such as high-throughput screening have
been designed to reduce animal testing while increasing the rate at which new drugs or
products are brought to market. It has become increasingly clear that cell–based assays will
provide the most information for these technologies to be effective in preliminary screening
of potential new drugs and products [1].
Convenient cell based systems for a wide variety of applications using a variety of cell types
representing key cell-types in various tissues are needed. Readily available cells on a fixed
substrate, such as a microtiter plate, that can be used with a minimum of preparation time
would not only decrease costs, but also increase the number and variety of assays performed
and potential products that are screened in a given amount of time. The idea of cryopreserving
cells on a fixed substrate is not new. Researchers have been attempting to cryopreserve cells
on a fixed substrate for some time using a variety of cells [2-9]. In general, cell survival in these
studies was lower that when the same cells were cryopreserved in suspension. Still, a method
has not been developed that can be applied to many different cell types and applications.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Most cells used in research are cryopreserved after addition of 10% dimethyl sulfoxide (DMSO)
to cells in suspension in cryovials, slow rate cooling, with or without induced nucleation, and
storage at-80°C or below-135°C. For most applications, this procedure is adequate to provide
viable, usable cells whatever the yield upon thawing. Often no consideration has been given
to how the cryopreservation process affects the cells and could potentially affect their function
upon thawing. Not only physical changes, such as water nucleating to form ice, but also
chemical changes take place as the temperature is reduced that subsequently affect the viability
and survival of cells and tissues upon thawing. As the temperature is reduced, heat is removed
and molecular processes are slowed which leads to a variety of structural and functional
changes within the cells even before freezing. As a consequence, the cell experiences a cascade
of biochemical and biophysical changes that sensitize the cell to further injury and can lead to
irreversible damage. For example, the rate at which cells are cooled and rewarmed is known
to be a major determinant of cell survival. As the temperature of the system is reduced, ice
forms initially in the extracellular space. Pure water separates as ice crystals so that solutes are
concentrated in the remaining liquid phase. As a consequence water moves out of the cell
across the plasma membrane in an effort to reestablish osmotic equilibrium within the
extracellular space. If the cells are cooled too rapidly, less time is allowed for water to move
out of the cells and intracellular ice occurs causing irreparable cell damage. If cells are cooled
too slowly, more water is allowed to leave the cells increasing the solute concentration within
the cell (Figure 1). This increase in solute concentration both inside and outside the cell has
been termed “solution effects” injury because it encompasses a number of changes that include
increased salt concentrations, which can denature proteins and membranes, precipitation of
buffers, induced pH changes, increased concentration of proteins may result in cross linking,
or simply removal of structurally important water. Usually an intermediate cooling rate
provides the best compromise between cytotoxicity due to cryoprotectants (CPAs) and ice
formation. During rewarming the process is reversed, ice is replaced with water, and cryo‐
protectants (CPA) are removed from the system. However, physical and chemical changes to
bring the cells back to physiologic temperature can still cause damage. As the sample is
warmed recrystallization can occur. Recrystallization is when metastable ice crystals that
formed during freezing are given an opportunity to reform larger crystals during rewarming.
These ice crystals can cause damage to the cells in a similar manner as those crystals that were
formed during freezing. Another concern during rewarming is the removal of the cryopro‐
tectants. The CPAs were added to the samples prior to freezing and cell permeating com‐
pounds like DMSO, replace cell water further decreasing the risk of ice damage. However,
during rewarming, DMSO does not move across the cell membrane as readily as water. An
imbalance can develop so that the cells will tend to take up water faster than the DMSO is
removed causing swelling. Too much swelling can cause irreversible cell damage if the
rewarming is not controlled appropriately, even if the freezing protocol worked. All these
factors affect the overall survival of cells during cryopreservation. Some cells can be cryopre‐
served readily, such as hematopoietic stem cells and fibroblasts, while other cell types are much
more difficult, such as hepatocytes. Therefore, optimization for a given cell type is usually
required, particularly if they are adherent [1,10-12].
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Figure 1. Comparison of differing cryopreservation strategies. If the cells are cryopreserved by freezing ice forms (blue
crystals) initially in the extracellular environment and the cells undergo cooling rate dependent shrinkage due to os‐
motic dehydration. The slower the cooling rate the longer intracellular water has the opportunity to move out of the
cell by osmosis due to the increasing osmolality of the extracellular environment as water is incorporated into ice crys‐
tals. Maximum cell viability is usually achieved at an intermediate cooling rate that balances osmotic dehydration and
the risk of intracellular ice formation. Rapid cooling permits intracellular ice formation and usually leads to cell death
upon rewarming. Very slow cooling may lead to excessive cell dehydration and cell death.
In addition to the physical and biochemical changes that take place within the cell during
cryopreservation, there is the added parameter of attachment to a substrate that must also be
taken into consideration. As described in this chapter, considerable time has been spent
developing procedures to cryopreserve cells on a fixed substrate, microtiter plates in particular.
However, the protocols described below can be applied to cells fixed on other types of
substrates such as a glass slide or a three dimensional scaffold for the purpose of making a
tissue engineered construct. The purpose of the CryoPlate™ concept is to provide cells on
plates that are ready to use for any number of applications, toxicology testing being one of
many. Ideally, any cell type of interest could be cryopreserved on plates and then be ready to
use with a minimum of processing time. In practice, no two cell types behave exactly alike
when cryopreserved, however, basic criteria and protocols can be established and then
adjusted and optimized to fit a specific cell type. While strict criteria have not been established,
some basic parameters, specifications, were necessary to guide the development of the
CryoPlate™ concept. These are (1) uniform cell number in all the wells within the microtiter
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plate (2) >80% of the cells in all the wells are viable (3) the specific activity of a given cell type
is intact (4) reproducibility; the retention and viability of the cells is similar in independent
experiments after cryopreservation (5) ease of processing; the steps involved in thawing the
plate and readying the cells for a specific assay should be user-friendly, not requiring special
handling, and not be time-consuming. Potentially any adherent cell type could be established
within our system including modified cell lines that may contain plasmid constructs. Such a
system would provide cells that are ready to use with a minimum of preparation time and
would also be conducive to automation and miniaturization.
2. Materials and methods
Cells: Two cell lines were used in these studies. One comes from rat thoracic aorta called A10
(ATCC# CRL-1476), and the second comes from bovine corneal endothelium, BCE (ATCC#
CRL-2048). Both cell types were grown and maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) with 10% fetal calf serum (FCS) at 37°C with 5% carbon dioxide.
Cryopreservation Methods: For cryopreservation experiments, different cryoprotectant formu‐
lations, the plates were placed on ice and increasing concentrations of cryoprotectant(s) added.
Then the final cryoprotectant solution was added and left for 10 minutes on ice before being
cooled at a controlled -1.0°C/min. rate to –80°C with or without nucleation at-6°C as described
in the text. The plates were stored at ≤–135°C in vapor phase nitrogen or in a mechanical storage
freezer. The plates were thawed rapidly at 37°C using a water bath for single step thawing.
For the two step thawing, plates were left at an intermediate temperature before rapid thawing
at 37°C using a waterbath or some other device as described (US Patent #6,596,531) [17]. The
cryoprotectant solution was then removed, the wells washed with 0.5M mannitol and culture
medium before being left in media for a 1 hour recovery period at 37°C in a tissue culture
incubator.
Measurement of Cell Viability and Proliferation: Cell metabolic activity will be assessed using the
resazurin reduction assay (alamarBlue™) [13]. Reduction of resazurin to resorufin measures
the oxidation/reduction reactions taking place within cells. Resazurin was added directly to
the wells in culture medium and incubated for 3 hours at 37°C. Upon reduction of resazurin
to resorufin a color change occurs and this color change can be measured and quantified. The
culture plates were read using a Gemini EM fluorescent microplate reader (Molecular
Dynamics) at an excitation wavelength of 544nm and an emission wavelength of 590nm.
Viability is expressed either in percent of untreated controls or after correction, using relative
DNA content, for cell losses. In addition to measuring viability after rewarming, the ability of
the cells to proliferate was also examined. Because resazurin is non-toxic, it can be used
repeatedly without harming the cells [14-16]. Increased metabolic activity over time is
indicative of proliferation and decreased metabolic activity is indicative of cell death by
apoptosis, subject to verification as described below.
DNA Measurement: The proportion of cells remaining in the well of the microtiter plate after
cryopreservation can be assessed by measuring the DNA content of the cells within a given
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well. The Cyquant assay (Molecular Probes) uses a fluorescent dye to label nucleic acids that
can then be measured using a fluorescent microplate reader with an excitation wavelength of
485 nm and an emission wavelength of 538 nm. The assay includes a step using RNAse A
(Sigma) to eliminate the variable amount of RNA within individual cells and thereby provide
a direct measure of the DNA content of the cell alone.
Temperature Measurement: The temperature profiles for individual wells in a microtiter plate
were made using thermocouples placed in the middle of wells at the corners of the plate and
one well in the center. Several well configurations were evaluated including a 6 well plate
where each well contained a thermocouple. The cryoprotectant solution used for these
measurements was 1-2M DMSO. Temperature measurements were taken using a datalogger
(Omega). Measurements were made every 5 seconds to 5 minutes depending on the rate of
warming or cooling being measured.
Evaluation of Apoptosis: Adherent cells were cryopreserved using our protocol and apoptosis
was evaluated using Nexin staining. Nexin stain binds to phosphatidylserine that translocates
to the outside of the membrane during apoptosis. After thawing, cells were allowed to recover
for 1 hour at 37°C. Cells were detached from the bottom of the well and then incubated with
nexin stain for 20 minutes at room temperature. Then the samples were run through the Guava
cell analysis system which counts the cells and measures the staining in a similar manner as a
flow cytometer [16].
Statistical Methods: All experiments were performed several times. The statistical analysis used
included t-test, ANOVA and logistic regression methods as appropriate for the type of data
being analyzed.
3. Results
3.1. Initial protocol setup
Simple cooling of a commercial microtiter plate by conventional means results in variable
thermal profiles. The objective is to have uniform conditions across the plate such that the
thermal history of the cell populations in each well of the plate is not significantly different
from each other. Conventional wisdom in cryobiology has established that cell survival is
markedly influenced by thermal history and the temperature profiles experienced during
cooling and warming.
Cryopreservation experiments using adherent A10 cells were initially performed in a fashion
similar to that typically done with ampoules of suspended cells and two assumptions were
made. First, adherent cells can be cooled successfully at a similar rate as the same cells in
suspension,-1.0°C/minute. Second, that thawing should proceed as rapidly as possible at 37°C,
the same as for cells in suspension. A10 cells were exposed to 2M DMSO then cooled at -1.0°C/
minute to -80°C before being stored overnight at <-135°C. Thawing was performed by placing
the plate in a 37°C water bath with the water touching the bottom of the plate. The plate was
then placed on ice, DMSO was removed and saved along with subsequent washes to check for
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potential detachment of cells and whether detached cells were viable. Both the supernatants
and any cells in the wells of the plate after rewarming were checked for viability using the
metabolic indicator alamarBlue™.
Measurement of viability after thawing demonstrated essentially no cell survival. When these
same cells were cryopreserved as cells in suspension using the same concentration of DMSO
their viability was >70%. Several observations were made during this experiment. It was noted
that when the plate cooled the plastic constricted and contorted, changing the shape of the
plate, which then reversed itself upon rewarming. Most of the cells that had been attached
prior to cryopreservation were no longer attached after rewarming and were no longer viable
when assessed for metabolic activity.
In an effort to retain cells on the plate and maintain their viability, a two step warming
protocol was investigated. This assumed that the differential thermal properties of tissue
culture plastic and the adherent cells are influencing the extent of cell recovery. Particu‐
lar attention was paid to the rates of heat transfer during freezing and thawing. Since, in
general,  slow cooling  is  mandatory  for  optimum survival  of  cryopreserved mammalian
cells,  the subsequent experiments focused on the effect of warming conditions following
cooling at a standard rate of -1°C/min.
A two-step warming protocol was shown to improve the cell recovery in this adherent cell
model [17].  Frozen plates were removed from <-135°C storage and placed at 23°C in air
until the cultures reached 0 to -70°C. Sample temperature was recorded in representative
wells in the 96 well plates. Plates were then placed into a 37°C water bath to complete the
thawing process as rapidly as possible with due care not to allow the wells to warm beyond
0°C. The plates were then immediately placed on ice,  washed, and left  in culture medi‐
um for assessment of metabolic activity. Results from an experiment in which the temper‐
ature for transition from step 1 to step 2 was varied are shown in Figure 2. If the plate was
rewarmed to  -70°C and thawed rapidly  at  37°C,  there  is  little  difference  in  viability  as
compared  to  a  single  rapid  thawing  step.  However,  allowing  the  plate  to  rewarm  to
progressively  higher  temperatures  resulted in  improved viability  with  the  best  viability
measured when the plate was allowed to warm to -20°C before rapid thawing at 37°C. It
was  also  noted  that  the  more  gradual  rewarming  to  -20°C  allowed any  distortion  that
occurred due to the plate being cooled to such low temperatures (<-135°C) to subside so
that when rapid thawing commenced, no sudden structural changes in the plate occurred.
Using this new two step warming regimen, a preliminary experiment was done to evaluate
the effect of DMSO concentration using the same cell model, A10 cells. DMSO (0-5M) was
added to wells containing 2.5x104 cells and the plates were cooled and stored as previously
described. A representative experiment in which the cells were warmed to –20°C in step 1 of
the warming protocol is shown in Figure 3. 1-2M DMSO provided the best protection for
adherent A10 cells against freezing-induced loss of viability. These experiments yielded
approximately 25-35% of the original cell viability prior to cryopreservation.
While viability improved with 1-2M DMSO, a greater increase was desired. However, this
series of experiments did demonstrate that adherent cells could be cryopreserved on plates.
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Further work was required to optimize the protocol to improve cell viability after cryopreser‐
vation and also, to evaluate and optimize the viability using an entire plate. With the advance‐
ments in high throughput screening and the push to reduce the number of animals used in
research, the ability to cryopreserve cells across an entire multiwelll plate would further the
development of cell-based assays providing suitable alternatives to animal testing.
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Figure 2. Cell viability after varying the transition temperature from slow to rapid warming of cryopreserved cell cul‐
tures. The viability of A10 cells was assessed after cryopreservation in 1M DMSO. Plates were removed from –130°C
and placed at ambient temperature (23°C) for slow warming to temperatures ranging from 0 to –70°C, whereupon
the plates were transferred to a 37°C water bath for rapid warming to ~ 0-4°C. Then metabolic activity was measured
using alamarBlue™.
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Figure 3. Cell viability of adherent vascular smooth muscle cells cryopreserved in the presence of varying concentrations
of DMSO. A10 cells were plated, exposed to varying concentrations of DMSO and cooled at-1ºC/min to –80°C then stor‐
ed at –130°C. The plates were warmed in two steps as described in the text and metabolic activity was measured.
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3.2. Warming rates
Having developed a warming protocol that retains cells on the plate and maintains their
viability, attention was then paid to optimizing the warming protocol for a complete multiwell
plate. Initial observations of cell viability across a plate (Figure 4) after rewarming demon‐
strated regional variations in cell viability with the highest survival being recorded from wells
at some edges of the plate.
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Figure 4. Variability of cell viability in a 96-well plate. Cells were cryopreserved in 1M DMSO. The plate was warmed at
23°C in air to –20°C and then warmed rapidly in a 37°C water bath. The plate was then placed on ice and the cells
were washed to remove the DMSO. Cells were left in culture media and alamarBlue™ for assessment of metabolic
activity. The results are typical of several experiments. Data from wells with cells minus background in rows A-G. The
control wells (background) without cells were in row H.
This effect might be explained by the orientation of the plate during cooling in the control rate
freezer leading to differential thermal conditions at various locations in the plate. However,
experiments done that evaluated the orientation of the plate within the freezer demonstrated
that edge effects were due to the plate and not where the plate was located in the control rate
freezer (data not shown). Since warming conditions had already been indicated to be a
determinant of cell viability, measurements of the thermal history of different wells in a typical
frozen plate during rewarming were measured.
Thermocouples were placed into wells at each corner of the plate and in one well at the center
of the plate. Temperature profiles were measured every 15-60 seconds using a datalogger
(Omega). The plate was stored at >-130°C overnight. The next day, the plate was rewarmed at
ambient temperature (~25°C). The well at the center of the 96-well plate had a different
warming profile compared with wells at the outer corners (Figure 5). Uniform conditions of
freezing and thawing are necessary in order that optimum conditions for cell survival are
applied consistently to each well in the plate.
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Figure 5. Warming rates at various locations in a 96 well plate. Each well was filled with 150 µl of 1.5% agarose and
allowed to solidify. Warming rates were determined using thermocouples placed in the corners and a middle well of a
96-well plate. Warming rates were determined by recording temperatures every 15 seconds using a datalogger (Ome‐
ga) that records the temperature from all the thermocouples simultaneously.
Warming the plates uniformly proved to be a challenge. An adjustment was made to the initial
two-step warming protocol to simplify the procedure. Originally, the two-step protocol called
for removing the plate from the cryofreezer and allowing it to warm in air at ambient tem‐
perature to –20°C in the first step. This procedure was cumbersome from the point of view of
having to carefully monitor the warming process to –20°C in air to ensure there was no thermal
overshoot. This problem was solved by placing the CryoPlate™ in a –20°C freezer for the
intermediate warming step. An equilibration time of 30 minutes was used and was based on
temperature measurements made that defined this time period as the minimum period
required to equilibrate the plate to -20°C. The next step was to thaw the plate quickly at 37°C.
With this modification, the intermediate temperature of -20°C was reached without the danger
of thermal overshoot and it also simplified the warming protocol. It also had the added benefit
of establishing a consistent temperature across the plate before the rapid warming step, so that
any variations during rapid warming across the plate were kept to a minimum. Steps were
also taken to improve thermal conductivity and provide more heat transfer between the
CryoPlate™ and the environment by employing custom-made heat sinks and thermal
conductive paste. Aluminum heat sinks designed to fit flush with the bottom of the microtiter
plate were used for the equilibration at –20°C and for the rapid thawing at 37°C. The wells of
the plate were filled with 50 µl of 1M DMSO in PBS and cooled to ~-130°C. The plates were
then allowed to equilibrate in a –20°C freezer for up to 30 minutes, and then the plate was
placed at 37°C for rapid thawing to the termination temperature of 0°C. Temperature meas‐
urements were made and warming profiles were determined as previously described. As
mentioned previously, distortion of the plate occurs during cooling. This distortion compro‐
mised the tight fit with the platform of the heat sink. To counteract this shape change, we used
a thermal conducting compound (Wakefield Engineering) to interface between the plate and
the heat sink. The marked effect of this modification is illustrated in Figure 6, where it is seen
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that significantly improved uniformity was achieved using the heat sinks in conjunction with
the thermal compound. The large disparity in warming rate previously observed between the
edges and the middle of the plate was alleviated using the heat sinks with the thermal
conduction compound.
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Figure 6. Warming temperature profiles. The wells of a 96-well plate were set up and cooled as described in the text.
The plate was then removed from cryostorage and placed in a –20°C freezer until equilibrated before being transfer‐
red to 37°C for the second step of the warming protocol. Temperatures were measured every minute while at –20°C
and every 5 seconds while at 37°C. Graphs (A) and (C) are without heat sinks while graphs (B) and (D) are done with
heat sinks and thermal conducting compound
3.3. Cooling conditions
Having established a protocol that uniformly warms wells across a multiwell plate, attention
was focused on defining a uniform cooling profile. Cooling rate is one of several cryobiological
variables that can impact cell survival and is usually cell type dependent. Slower cooling rates
while discouraging undercooling of the samples and the formation of ice inside the cell do
allow for longer exposure times to cryoprotectants and time for osmotic changes to occur that
promote cell shrinkage which conceivably have a negative impact on the stability of the cell-
substrate interactions. Faster cooling rates reduce exposure to the cryoprotectant and osmotic
Recent Advances in Cryopreservation10
changes to the cell but do allow undercooling to occur and can also allow for the formation of
ice inside the cell. A balance between these two extremes has to be optimized in order for
maximum cell survival to occur. A system using 96-well plates, presents unique challenges in
terms of uniform cooling across the plate as well as providing an optimum cooling rate for a
particular cell type. Several cooling rates were examined and included, -0.2°C/min, -0.5°C/min,
-1.0°C/min, -3.0°C/min, -5.0°C/min, and -10.0°C/min. Cooling rate measurements for each
cooling profile were taken for 3 separate runs. Two different sample volumes were evaluated,
100 µl/well and 50 µl/well. For these experiments, the ambient environment of the microtiter
plates was uniformly cooled using a programmable controlled-rate freezer (Planar Kryo 10).
Not surprisingly, slower rates, such as -0.2°C/min, provided more uniform cooling as opposed
to faster rates like -10.0°C/min (Figure 7). However, increasing the volume of cryoprotectant
medium within the wells of the plate did affect the ability of the controlled-rate freezer to cool
the samples uniformly.
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Figure 7. Cooling temperature profiles. All wells of a 96-well microtiter plate (Falcon) were filled with 50 µl of 1M
dimethyl sulfoxide (DMSO) in phosphate-buffered saline (PBS). Thermocouples were inserted into the corner wells and
a middle well. The temperature was measured every 5 minutes using a datalogger (Omega) for a rate of –0.2°C/min
(A) and every minute for a rate of –10.0°C/min (B).
Cooling profiles at the different locations in the plate were more uniformly controlled when
the smaller sample volume was employed (Figure 8). Variations between the well locations
were greatest in the region of nucleation when the latent heat of crystallization is evolved
(referred to as the latent heat bump in the cooling curve and occurring at approx –5°C in this
protocol). This is important because varying degrees of undercooling and the consequential
variable cooling rates in the immediate post-nucleation phase are known to influence cell
survival [18]. Nucleation is a statistical event that is known to depend upon a number of factors,
of which sample volume is critical. For example, cryopreservation of cell suspensions is
conventionally carried out in ampoules containing sample volumes of 1 mL or greater. In such
cases it is usually observed that spontaneous nucleation occurs at widely different tempera‐
tures between ampoules. In other words, there is a variable degree of undercooling between
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samples before heterogeneous nucleation is initiated. This undesirable phenomenon has led
to the common practice of induced nucleation (so called “seeding”) to ensure uniform
conditions between replicate samples in a cooling run.
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Figure 8. Cooling temperature profiles with different volumes. Plates were set up as described for Figure 1. The plate
was cooled at –1.0°C/min to –80°C in a controlled-rate freezer (Planar) and the temperature was measured every mi‐
nute using a datalogger (Omega). (A) 50 µl/well, (B) 100µl/well.
On the assumption that the five strategic measurement locations in this study are representa‐
tive of all the wells in a plate, it appears that the spontaneous nucleation of 50µl samples (Figure
8A) is reasonably consistent and more so than the 100µl samples (Figure 8B). Unlike dealing
with the freezing of a few ampoules, manual seeding of multiple samples, or simultaneous
seeding of all the wells in a microtiter plate, is not practically feasible. Manufacturers of
programmed cooling machines have attempted to deal with this by offering the facility for
forced nucleation by a momentary sharp drop in ambient temperature initiated by a blast of
refrigerant into the cooling chamber. A cooling profile developed in our lab for routine use in
screening cryoprotectant solutions on plates that is a modification of a standard –1.0°C/min
cooling rate includes a sudden temperature drop to initiate nucleation. It is included here for
comparison purposes with regards to conventional cooling profiles, such as –1.0°C/min, and
for its potential benefits in terms of cell viability and cell attachment.
From the results presented (Figure 9), it is clear that lower cooling rates provide better cell
viability and cell retention (p<0.001). For the cells used in these experiments, bovine corneal
endothelial cells (BCE), cooling rates above –1.0°C/min demonstrated reduced viability and
cell retention. Equivalent cell viability and attachment was observed with cooling rates of –
1.0°C/min or less. The modified cooling profile (MP) also demonstrated viability equivalent to
a standard –1.0°C/min cooling rate, but better cell attachment after thawing.
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Figure 9. Cell viability and attachment after cryopreservation with varying cooling rates. BCE cells were plated and
cryopreserved in 1M DMSO. After thawing metabolic activity (A) and cell attachment (B) via DNA content were meas‐
ured.
3.4. Cryopreservation in bulk solution vs. air
Another option that was tried was to compare cryopreserving BCE cells in solution versus
exposing the cells to CPA and then removing the supernatant to cryopreserve the cells in air.
This set of experiments was included on the basis of previous work that showed an improve‐
ment in viability of whole corneas when they were cryopreserved in air [19-20]. BCE cells were
plated at 20,000 cells/well and cryopreserved in 2M DMSO or 2M 1,2-propanediol (PD). Upon
thawing, using the two-step warming protocol, cell viability and cell retention was assessed
(Figure 10A). Both DMSO and PD mean cell viability was significantly higher for cells
cryopreserved in bulk solution compared with those frozen in air (p<0.001). Cell retention
determined as DNA content, showed a somewhat similar trend between these two modes of
cryopreservation. In the presence of DMSO there was a significant difference between air and
bulk medium, with an improvement in cell retention observed when cells were cryopreserved
in bulk solution (p<0.001). For PD, freezing without bulk medium (in air) resulted in the highest
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Figure 10. Cryopreservation with and without bulk solution. BCE cells were cryopreserved in 2M DMSO or 2M PD in
bulk solution or in air. The graphs for DMSO represent the mean (±SEM) of 252 replicates. Graphs for PD represent the
mean (±SEM) of 92 replicates. Statistical analysis done by 2-way ANOVA and presented in the summary.
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retention of cells (100%) over freezing in bulk solution (p<0.001). It thus appears from these
studies that there is a complex relationship between the nature of the CPA and the role of the
surrounding medium (liquid or air) in determining both cell retention and cell viability.
Moreover, it appears that in this system using BCE cells attached to plastic, a different response
is achieved compared with corneal endothelial cells cryopreserved in situ in their native state
in whole corneas [20].
3.5. Exogenous nucleating agents
Still another approach was to include an inert nucleating agent within each sample to promote
nucleation uniformly at, or just below, the equilibrium freezing point. Such an agent is the
commercial product “Snowmax” used effectively in the snow-making industry at ski resorts.
We used this product as a tool to compare spontaneous nucleation with enforced nucleation
in our system. However, addition of the nucleating agent did not improve the uniformity
demonstrated in Figure 7, which was generated in the absence of Snowmax. It is concluded
therefore, that slower cooling rates such as -1.0°C/min used with a microtiter plate containing
50µl samples per well yields sufficiently uniform cooling without the need for artificial
nucleating techniques.
3.6. Effects on cell survival
Having demonstrated the development of a cooling and warming protocol with satisfactory
uniformity across the entire plate, the next step was to examine the effect upon cell survival.
To this end, we dispensed BCE cells into each well of a 96-well plate and cryopreserved them
in 2M DMSO. The plates were thawed using the modified warming protocol with heat sinks
and thermal conduction compound (Figure 11). Recovery of cells and their viability at each
location in the plate showed that with the exception of the left edge cell viability was uniform
across the entire plate. Interestingly, the left edge of the plate demonstrated viabilities greater
than the rest of the plate. Why the other edges do not also demonstrate this effect is unclear.
The Cyquant assay measures the DNA content of the cells which is indicative of cell number
and is a measure of cell retention on the plate after cryopreservation, was done on the same
plates after Alamar Blue. Observation of this data showed that the middle of the plate
demonstrated better cell retention than any of the edges.
The data from these experiments was obtained using the modified –1.0°C/min cooling profile
(MP) mentioned above that includes a sudden temperature drop to facilitate nucleation.
Experiments were also done using other cooling rates such as –0.2°C/min which did not
produce more uniform cell viability and cell retention as would be anticipated based on the
temperature profile data (see Figure 7). While the temperature profile data showed that a lack
of induced nucleation did not affect uniform cooling, nucleation is a statistically random event
and does have a significant impact on the survival of the cells being frozen. Based on the cell
viability and cell retention data, it is likely that heterogeneous nucleation is taking place even
though the temperature profiles of the five wells that were being measured did not indicate
it. The data using the modified cooling profile supports this assumption (Figure 9) because it
is designed to initiate nucleation across the plate in a limited way and better cell viability was
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measured when it was used. Therefore, controlled nucleation across the plate is a desirable
objective to promote more uniform cell survival.
A system for nucleating all the wells of a 96 well plate was designed. The idea for this system
involves using an external liquid nitrogen source. The nucleation manifold consists of spring
loaded metal pins, one for each well of a 96 well plate. The plate of pins sits on an aluminum
block that allows liquid nitrogen to be pushed through it, thus cooling the block to tempera‐
tures well below freezing (~-100°C). Nucleation is achieved by cooling the microtiter plate to
a temperature near the freezing point of the solution then pressing the plate onto the spring
loaded pins that have been cooled to a much lower temperature. Once nucleation occurs the
plate is removed from the pins and the cooling cycle can continue until complete. A represen‐
tative profile using the manifold and showing nucleation of the corner wells and middle wells
of a 96 well plate is presented (Figure 12). Note that each well nucleates within the time span
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Figure 11. Plate uniformity with cells. BCE cells were plated at 2x104 cells/well and cryopreserved in 2M DMSO. Thaw‐
ing was done as described in the text. Cell viability (top) and cell retention (bottom) were assayed by Alamar Blue and
Cyquant, respectively. The graph represents the layout of a 96-well plate and is the mean relative fluorescence units
(RFU) for each well from three experiments. Rows A-G contain cells. Row H represents control wells with no cells and is
not shown.
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of ~30-45 seconds and that the variation in the temperature at which nucleation is initiated and
the amount of latent heat released is minimal.
 
Latent heat of fusion 
Ice nucleation 
Figure 12. Temperature profile using nucleation manifold. Thermocouples were placed in the corner wells and middle
wells of a 96 well plate. Temperatures were recorded every few seconds.
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Figure 13. Cell viability and cell attachment of BCE cells after cryopreservation using the nucleation manifold. BCE cells
were plated in each well of a 96 well plate and left in 2M PD-EC before being cryopreserved using the nucleation
manifold. Viability was measured by alamarBlue™ and DNA content was measured by the Cyquant assay. (left) cell
viability. (right) cell attachment.
Experiments were then done to determine whether or not more uniform viability and cell
attachment was achieved using this nucleation device. This experiment was performed many
times using both DMSO and PD as the CPA. Figure 13 is a representative experiment where
viability and cell retention were measured. It was easier to achieve more uniform viability then
cell retention. Having done this experiment many times we have noted user variation. Pressure
Recent Advances in Cryopreservation16
applied to the plate sitting on the pins is applied strictly by the user using a lever. It has been
noted that variations in the handling of the lever produced variations in the uniformity of
nucleation across the plate. The experiments to date certainly support the mechanism of
nucleation that has been developed, but it is obvious that further optimization of this apparatus
is required to improve the uniformity of viability and cell retention across the plate.
4. Other parameters
In natural tissues, or engineered tissue constructs, as well as cell monolayers, that could
conceivably be used for cell based assays, maintenance of cell-cell interactions as well as cell-
substrate adhesion will be important for full function after cryopreservation. Therefore, the
effect of cell confluency on the ability of cells to remain attached to a substrate during cryo‐
preservation was evaluated. Some research groups have suggested that a monolayer reacts
differently than subconfluent cell populations and demonstrated a loss of cells upon rewarm‐
ing. It is hypothesized that because the cells have contacts with each other, when one cell
becomes detached it will cause surrounding cells to detach also, even if those surrounding
cells are still viable [3]. Other groups agree that monolayers behave differently from subcon‐
fluent cell populations when they are cryopreserved, but argue that optimization of cryopre‐
servation variables such as cooling rate can produce cell viability and attachment values
consistent with subconfluent cell populations [21]. Various cell densities, both subconfluent
and a monolayer, were assayed for cell viability and cell attachment after cryopreservation.
BCE cells were plated on tissue culture plastic at varying densities up to a monolayer of cells
that consisted of 80,000 cells/well. After exposure to 2M DMSO, the plates were cryopreserved
at one of two cooling rates, either -1.0°C/min or with the modified -1.0°C/min cooling profile
(MP). The results presented in Figure 14 demonstrated similar cell viabilities regardless of the
cell density assayed. More confluent cell populations showed better cell retention compared
with more sparsely populated wells (i.e: 2,500 cells/well vs 20,000 cells/well). Slower cooling
rates were also evaluated (data not shown) with similar results. It can be concluded, that in
this system, the degree of confluency does not greatly impact cell viability and cell retention
after cryopreservation. However, different cell types may behave differently when cryopre‐
served as a monolayer. In addition, the previous studies cited used glass cover slips and
microtiter plate filter inserts to study the cryopreservation of a monolayer while viability and
cell retention were evaluated on tissue culture plastic in the present study.
In a related experiment, BCE cells were cryopreserved in two different cryopreservation
solutions, 2M DMSO and 2M PD, at a subconfluent density of 20,000 cells/well and as a
monolayer at 80,000 cells/well (Figure 15). No significant differences in viability or cell
attachment were observed. While initial viability was only 50%, the cells were able to initiate
proliferation within 24 hours post thaw and continued to proliferate at 4 days post thaw. Cell
attachment was very good with values that were 75% or greater based on an untreated control
demonstrating that the monolayer was just as robust as the subconfluent population after
cryopreservation.
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Figure 15. Percent cell viability and DNA content of a subconfluent cell population and a cell monolayer after cryopre‐
servation. BCE cells were cryopreserved in 2M DMSO in HBSI or 2M PD in EC at the indicated cell densities. Viability was
measured by alamarBlue™ and DNA content was measured by the Cyquant assay (Molecular Probes). Percent viability
and DNA content is the mean (±SEM) of 10 replicates.
4.1. Optimized system
Having optimized the cooling and warming protocols for cryopreserving cells in a multiwell
plate, experiments were then done to evaluate the system and how well it could be used to
measure cell viability in cryopreservation experiments. Two commonly used cryoprotectants,
DMSO and PD were assessed in Euro-Collins (EC), a well established vehicle solution used in
cryopreservation, at concentrations of 0-4M. BCE cells were plated at a density of 20,000 cells/
well and exposed to DMSO and PD before being cryopreserved using the modified –
1.0°C/min protocol. The graphs depict cell retention for both CPA and their viability after
cryopreservation (Figure16). For both CPAs, concentrations of 1-2M demonstrated the best cell
viability and attachment. Higher CPA concentrations showed viability and attachment that
was significantly worse (p<0.01). At a concentration of 2M PD, cell viability of ~77% was
observed versus only ~50% for the same concentration of DMSO. For both cell viability and
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Figure 14. Cell viability and attachment after cryopreservation for varying cell densities. BCE cells were plated from
0-80,000 cells/well and cryopreserved as indicated in the text. Cell viability (A) and cell retention (B) were assessed and
the data represent the mean (±SEM) of 12 replicates. Cell density is expressed using a log scale.
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cell retention after cryopreservation, PD demonstrated better values over DMSO at all
concentrations evaluated (p<0.001). DNA content values of >75% were achieved using 2M PD
in EC over the same concentration of DMSO which achieved values of only ~60-65%. Taking
this a step further, an evaluation of the viability of those cells still attached to the plate was
done, expressed as adherent live cells (Fig. 16 E and F). It was observed that adherent cells
were >60% live (viable) for all concentrations of DMSO tested and >70% for all concentrations
of PD. So, cells that remained attached after cryopreservation had a high level of viability at
Figure 16. Cell viability and retention after cryopreservation. BCE cells were plated and cryopreserved as descr
in the text using the modified –1.0oC/min cooling profile. Graphs A & B show DNA content which is indicative of cell 
retention. Graphs C & D show cell viability. Graphs E & F show viable adherent cells. All graphs represent the mean 
(±SEM) of 12 replicates. Statistical analysis done by 2-way ANOVA and presented in the summary. 
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Figure 16. Cell viability and retention after cryopreservation. BCE cells were plated and cryopreserved as described in
the text using the modified –1.0°C/min cooling profile. Graphs A & B show DNA content which is indicative of cell
retention. Graphs C & D show cell viability. Graphs E & F show viable adherent cells. All graphs represent the mean
(±SEM) of 12 replicates. Statistical analysis done by 2-way ANOVA and presented in the summary.
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optimal CPA concentrations. Further study of other cryoprotectants could yield even better
viability and cell attachment values. In our experience to date, the CryoPlate™ protocol works
for most cells we have evaluated but the optimal CPA requirement varies.
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Figure 17. Cell viability and retention after cryopreservation using macromolecular CPAs. BCE cells were plated at
20,000 cells/wells, exposed to the above compounds at the indicated concentrations with 2M DMSO in EC and cooled
using the modified –1.0°C/min cooling program. Graphs A, C & E show cell viability and graphs B, D & F show DNA
content. All graphs represent the mean (±SEM) of 12 replicates. Statistical analysis done by 2-way ANOVA.
In a second series of experiments, non-permeating macromolecular cryoprotectants were also
examined in combination with the cell permeating cryoprotectants DMSO and PD. Chondroi‐
tin sulfate (CS), dextran sulfate (DS) and polyvinylpyrrolidone (PVP) were assayed at various
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concentrations (0-10%) in the presence of 2M DMSO for their ability to enhance viability and
cell retention. Concentrations higher than 10% for each of the CPAs suggested proved to be
difficult to get into solution above 10%, hence this defined the upper limit of the concentrations
tested. BCE cells were assayed for cell viability and DNA content as described above and the
results are presented in Figure 17. Using 2M DMSO as a baseline, which demonstrated a cell
viability of ~40% with a DNA content of ~55%, enhancement of viability (p<0.001) and cell
retention (p<0.05) was observed with CS. A concentration of 1% CS in 2M DMSO demonstrated
cell retention at ~100% with viability at ~75%. Dextran sulfate did not improve viability or cell
retention over 2M DMSO alone. At the best concentration of dextran sulfate (5%), viability and
cell retention were equivalent to using just 2M DMSO. Cell retention was improved over 2M
DMSO alone with all concentrations of PVP examined (p<0.05) but only a slight improvement
in cell viability at a concentration of 2.5% PVP. In summary the only macromolecular cryo‐
protectant that demonstrated benefits for cells with regards to cryopreservation was chon‐
droitin sulfate. In fact this combination provided results that were not significantly different
compared with untreated controls. Chondroitin sulfate is readily found in association with the
extracellular matrix of cells and this may explain why greater viability and cell retention were
observed compared with the other macromolecular CPAs that were evaluated.
4.2. Carrier solution
Different carrier solutions were evaluated to determine if they had an impact on cell viability
during cryopreservation. Others have reported the significance of the cryoprotectant carrier
solution to overall viability after preservation [22-24]. In this experiment, four carrier solutions
were used, Dulbecco’s Modified Eagles Medium (DMEM), Euro-Collins (EC), a well estab‐
lished organ preservation solution, Hepes-buffered saline (HBSI), and Unisol (UHK), a
preservation formulation developed in our labs. BCE cells were exposed to 2M DMSO in the
carrier solutions listed and then cryopreserved using the optimized cooling and warming
conditions described above, Cell viability was assessed by measuring metabolic activity
immediately after thawing and for several days post thaw. The best viability was observed
when cells were cryopreserved in either HBSI or UHK. Viability was as high as 70% and there
was evidence of recovery and proliferation by day 3 post thaw with an increase in viability
close to 100% of untreated controls. The least viable cells were observed while cryopreserved
in EC and their recovery post thaw was also minimal. Using this system, it was observed that
the choice of carrier solution can have a significant impact on cell survival. It is likely that
different vehicle solutions may combine effectively with other CPAs.
4.3. Apoptosis
Using our system for cryopreserving cells on plates, apoptosis was evaluated. The nexin
staining assay was performed and measured using the Guava Cell Analysis System on cells
that had been cryopreserved as a monolayer and as a subconfluent cell population in 2M
DMSO or 2M 1,2-propanediol (Table 1). Apoptosis was evaluated up to 2 days post thaw to
determine if apoptosis was occurring. Immediately after thawing, there was little if any
evidence for apoptosis. At day 1 post thaw, some apoptosis was occurring so that the percent
Cryopreservation of Adherent Cells on a Fixed Substrate
http://dx.doi.org/10.5772/58618
21
of viable cells had dropped to between 80-90%. However by day 2 apoptosis was detectable
at very low levels if at all.
Cell density CPA Day 0 Day 1 Day 2
Viable† Apoptotic* Viable† Apoptotic* Viable† Apoptotic*
20,000 cells/
well
DMSO 97.9 2.1 80.8 19.2 99.3 0.7
PD 94.2 5.8 82.7 17.3 95.5 4.5
80,000 cells/
well
DMSO 98.3 1.7 91.9 8.1 99.8 0.2
PD 97.7 2.3 88.5 11.5 98.9 1.1
† Viable cells are calculated as a percentage of the total cells counted: average number of cells counted is 1000
*Apoptotic values include early and late apoptosis events and any resulting dead cells
Table 1. Apoptosis in BCE cells after cryopreservation
4.4. Well configurations
In addition to the 96 well plate configuration, four other different well configurations were
evaluated for their ability to produce viable cells after cryopreservation using the cooling and
warming protocols established. As a first step, temperature profiles were measured for each
configuration. Six thermocouples were placed into wells at each corner of the plate and in two
wells at the middle of the plate. For the 6-well plate, a thermocouple was placed in each well.
Temperature profiles were measured every minute using a datalogger (Omega) during a
cooling profile of -1.0°C/minute in a controlled rate freezer (Planar). While it was anticipated
that for most of the cooling regime, the plate would follow the same cooling pattern as the
freezer, part of this process was to determine when the latent heat of fusion occurs, when water
changes to ice, and how significant the release of heat was. Using this information, a modified
protocol can be developed that would help alleviate the latent heat of fusion or at least reduce
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Figure 18. Cell viability of BCE cells after cryopreservation in different carrier solutions. Cells were cryopreserved in 2M
DMSO in the indicated carrier solutions. Percent cell viability is the mean (±SEM) of 12 replicates
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it to a level that causes minimal disruption to the cooling profile of the sample. In addition to
the 6-well and 384-well plates (Figure 18), 12-well and 24-well configurations were also
evaluated. Each well configuration demonstrated varying degrees of latent heat. The 384-well
demonstrated the most variable release of latent heat while the 6-well plate release of heat did
not appear to be as abrupt and was not as distinct as for the other well configurations.
This did not mean that the cooling profile for the 6-well plate was actually better, in fact, when
viability was measure for each of the well configurations (Table 2), the 6-well plate demon‐
strated the lowest cell viability and cell attachment. Cell attachment for all the well configu‐
rations except the 6-well plate demonstrated attachment values of at least 90% or greater as
compared with an untreated control. Viability was much more variable and was indicative of
the degree of latent heat observed during the recording of the temperature profiles for each
well configuration. Surprisingly, the 384-well plate demonstrated cell viability that was as
good as that observed with the 96-well plate. Every well of the 384-well plate was not evaluated
during these experiments and so while these results demonstrated that high viability values
are achievable, there is still may be an issue with uniform viability and attachment in every
well of a plate regardless of the well number and configuration.
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Figure 19. Temperature profiles for a 6-well and a 384-well microtiter plate. Thermocouples were placed into the cor‐
ner wells and middle wells of each plate. Temperatures were measured every minute with a datalogger during a cool‐
ing profile described in the text. The graphs represent one of several experiments performed for each well
configuration. (A) 6-well. (B) 384-well.
Cell Viability % Cell Attachment %
Well configuration Day 0 Day 3/5 Well configuration Day 0
6-well 25.845±1.04 127.81±6.66 6-well 43.12±8.79
12-well 24.53±1.20 125.25±3.72 12-well 90.32±3.93
24-well 43.73±1.50 185.35±6.60 24-well 94.66±3.05
96-well 71.52±16.28 81.76±14.84* 96-well 89.76±3.57
384-well 72.62±5.50 169.02±7.46 384-well 125.61±2.08
*Only the 96-well configuration viability is from day 3. All others are from day 5.
Table 2. Cell viability and attachment with differing well configurations
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5. Discussion
In this chapter, development of a method for cryopreserving cells on a fixed substrate has
been described (US Patent #6,596,531) [17].  Specifically,  a  CryoPlate™ protocol  has been
developed to freeze cells on microtiter plates. This protocol was developed in our labs as
a method for the rapid screening of cryoprotectant solutions. However, its application for
other  cell-based  assays  is  far  reaching.  Potentially,  any  adherent  cell  can  be  cryopre‐
served using this system for a variety of applications upon thawing.
Initial experiments using a traditional approach for cryopreserving cells in suspension that
involved slow rate  cooling and rapid thawing at  37°C produced no viable  cells.  It  was
noticed that as the polystyrene plastic plate cooled, the plastic  constricted and the plate
contorted or bowed at its edges. It was also noticed during the initial experiments that the
cells came off the plate. One can speculate that the sudden change in temperature causes
stresses resulting in the plastic changing shape, similar to what occurs when an ice cube is
placed in a warm liquid and it develops cracks. The sudden temperature change and abrupt
changes to the plastic culture plate as it warms causes the cells to be forcefully detached
and this  detachment  may trigger  the death of  the cell  via  apoptosis  or  other  cell  death
mechanisms.  Instead,  a  two step  warming protocol  was  tried  in  which  the  plates  were
warmed to  an intermediate  temperature  before  being rapidly thawed at  37°C.  The idea
being  a  more  gradual  warming  would  allow the  plate  to  readjust  to  warmer  tempera‐
tures without abrupt changes in its shape which would prevent the cells from coming off
during warming, promoting greater cell viability and attachment after thawing. The first
protocol involved removing the plates from cryostorage and leaving them in air (~25°C)
until they reached ~-20°C before undergoing rapid thawing at 37°C. Plates were then placed
on  ice  for  cryoprotectant  removal  and  subsequent  assessment  of  viability.  Using  this
protocol, viable cells were obtained after freezing.
Focus then shifted to applying these conditions across an entire plate. Preliminary measure‐
ments  of  temperature  at  strategic  locations  within  the  plate  demonstrated  differential
warming profiles. Uniform warming was achieved by removing the plate from cryostor‐
age and leaving the plate in a -20°C freezer for 30 minutes followed by rapid thawing at
37°C using an aluminum heat sink with thermal conducting compound prewarmed to 37°C
[17]. As mentioned previously, the intermediate incubation at -20°C allowed the plate to
warm enough to relax the plastic so that no distortion remained and also allowed all the
wells to equilibrate to a similar temperature before the rapid thawing facilitating uniform
warming  conditions.  As  was  observed  in  Figure  6,  uniform  warming  conditions  were
achieved.
Uniform cooling was also sought. In particular, synchronizing ice nucleation in each well
was a primary objective as this  would insure that all  the wells  of  a plate had a similar
cooling profile which should in turn produce similar cell viability upon thawing. A survey
of various cooling rates demonstrated that slower cooling rates were better at  achieving
similar  profiles  across  wells  including  more  synchronous  nucleation  than  faster  cooling
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rates. It was also noted that the volume of solution in the wells impacted the cooling profiles
of  measured  wells.  More  similar  cooling  profiles  were  possible  when  smaller  solution
volumes were used. However,  completely removing all  solution once the cells had been
exposed to cryoprotectants prior to freezing did not improve viability and in fact impact‐
ed cell viability negatively. Nucleation is a random event and so further steps were taken
to control nucleation so that all wells of the plate were nucleating together. The use of an
exogenous nucleating agent,  such as Snomax, was investigated and did not improve ice
nucleation uniformity. A modification to the -1.0°C/minute cooling profile was made that
included a sudden drop in temperature which promoted more uniform ice nucleation across
the plate. This improved the consistency of viability and cell retention across the plate, but
some variations still existed predominantly along the left edge of the plate.
Efforts were then made to further improve synchronous ice nucleation across the plate by the
application of a nucleation manifold. Described in the text, this device was designed to promote
ice nucleation across the plate in a controlled and timed manner. Further improvement in
uniform viability was observed, but uniformity of cell retention did not show any significant
improvement. As the nucleation manifold was considered a prototype, further improvements
are envisioned that would automate the process and remove variation cause by user incon‐
sistencies. There is also the possibility that cell retention is actually improved as well and that
the decreased uniformity of cell retention has to do with inconsistent cell plating prior to
cryopreservation. Further experiments are in progress to answer these questions and promote
more uniform cell retention that is consistent with cell viability values.
In addition to cooling and warming, other parameters were considered that might affect the
viability of cells attached to a plate. Cell confluency was felt to play an important role in
viability and retention of cells on a fixed substrate with the thought that subconfluent popu‐
lations would have better retention than a monolayer of cells. Monolayers have developed cell
to cell connections similar to cell-cell and cell-matrix connections that are present in tissues. It
was hypothesized that when one cell detached that would cause neighboring cells that had
developed connections to the detaching cell to come off the plate as well [21]. Experiments
done using our two step warming protocol demonstrated no difference between confluent and
subconfluent cell populations. Factors that promoted the detachment of the cells using a one
step thawing regime have been alleviated using a two step protocol so that confluency does
not have the same influence on outcomes as noted previously by other groups [3]. Maintenance
of a monolayer and its cell-cell interactions strongly suggests that our protocol could readily
be applied to tissue constructs such as skin equivalents or other types of three dimensional
constructs that would be used for drug testing and other applications.
Taking this a step further, nexin staining was performed on subconfluent cells and a monolayer
for several days after cryopreservation and thawing on plates to check for the induction of
apoptosis. Viability values remained high, ~95% of the counted population, even after 2 days
in culture following thawing and no differences were observed between subconfluent and
monolayer cell populations. Apoptosis induction was minimal demonstrating that our process
promotes cell viability and that the cells are able to function and are available for further assays.
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Application of our cryopreservation protocol to microtiter plates of differing well configura‐
tions showed variation of cell viability and cell retention that was not necessarily based on the
consistency of their cooling profiles. For example, while the 6 well plate demonstrated a
relatively consistent thermal profile across its wells, cell viability and cell retention were not
as good at 25% and 43% respectively. However, the best viability was observed using the
higher well configurations, 96 well and 384 well with cell viability at ~70% and cell retention
at >90% even though their cooling profiles were not as consistent or uniform as that observed
in the 6 well plate. Other factors are likely involved that influence cell viability during
cryopreservation in plates. The volume of the wells is one factor as was observed when thermal
profiles were compared using 50µl and 100µl in a 96 well plate. Smaller volumes produced
better thermal profiles. With regards to the 6 well plate, the larger volume in each well means
it is easier to cool each well consistently particularly at slower rates. However, at faster rates
a larger volume is harder to cool or rewarm while keeping the conditions consistent across
each well. This is likely why viability and cell attachment values are lower in a 6 well plate
versus a 96 well plate. Modifications to the two step warming protocol might be needed to
accommodate the changes in volume as the wells get larger so that better viability and cell
retention can be maintained.
The initial purpose behind the development of this protocol for cryopreserving cells on plates
was to develop a higher throughput system for screening possible cryoprotectant formula‐
tions. An example CryoPlate™ protocol, based on the studies presented here, is illustrated in
Figure 20. The plates are placed on ice and cryoprotectant(s) added either in a single step or
multiple steps of increasing concentration. When the final cryoprotectant solution has been
added it is incubated for 10 minutes on ice. Then it is placed in a precooled (4°C) control freezer
and once the temperature has returned to 4°C it is cooled at -1°C/min. rate to -80°C with
nucleation at -6°C. Then the plates are stored at ≤ –135°C in a vapor phase nitrogen or me‐
chanical storage freezer. The plates are thawed in at least two steps. First by placing in a –20°C
freezer for 30 minutes and second, by rapid warming, ~20°C/min. to 0°C, at 37°C. Rapid
thawing has been performed using aluminum heat sinks and thermal conduction compound
as well as a waterbath, both prewarmed to 37°C with similar results. This warming method
minimizes detachment during thawing (Figure 2). The cryoprotectant solution is then removed
in one or more washing steps and the plates are incubated for at least 1 hour at 37°C in cell
culture medium in a tissue culture incubator to allow cell recovery to occur. We usually utilize
rewarmed cell cultures after completion of a 1 hour recovery period.
A survey of several cryoprotectants, penetrating and non-penetrating, and cryoprotectant
carrier solutions was done (Figure 16) that demonstrated the utility and versatility of our
system allowing rapid selection of different cryoprotectants and carrier solutions as well as
their concentration with regards to the the specific cell type assessed. In this particular case
excellent cell viability was obtained combining 2 M DMSO and 1% (w/v) chondroitin sulfate
in EC solution (Figure 16A). We have since employed the CryoPlate™ method to cryopreserve
adherent endothelial cells with trehalose [15] and endothelial cells, smooth muscle cells and
heart valve leaflet myofibroblasts using either DMSO or PD formulations with acceptable high
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cell viabilities in combination with other carrier solutions [25-26]. Preliminary results also
indicate that our protocol is effective for preservation of human mesenchymal stem cells [28].
Based upon our experience to date, we anticipate that our CryoPlate™ protocol in combination
with various CPAs and carrier solutions can be adapted for many, if not all, cell-based assay
systems, and possibly tissue constructs. Cell-based assay systems and tissue constructs are
currently replacing animal testing, so methods that can preserve and facilitate the accessibility
of these types of systems are needed. Our protocol cryopreserving attached cells on microtiter
plates fulfills this need and is versatile so that it can be applied to a wide variety of cell types
for different applications.
Plate cells 
(subconfluent or monolayer) 
 
Add cryoprotectants 
(plate on ice) 
 
Allow plate to equilibrate at 4oC for 10 minutes 
 
Cool plate to -80oC using control rate freezer 
at -1oC/minute with nucleation step 
 
Store <-135oC 
 
Allow to equilibrate at -20oC for 30 minutes 
 
Rapid thawing at 37oC 
(heat sink or waterbath) 
 
Cryoprotectant removal and cell washing 
(plate on ice) 
 
Cells ready for assessment 
Figure 20. Example CryoPlate™ protocol for cryopreserving cells on microtiter plates.
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